Merit Medical Systems (MMSI) EBITDA (2010 - 2026)

Merit Medical Systems has disclosed EBITDA across 17 years of filings, most recently posting $60.4 million for Q2 2026.

• In Q2 2026, EBITDA rose 28.85% year-over-year to $60.4 million; the TTM figure through Jun 2026 stood at $201.4 million (up 24.5% YoY), while the FY2025 annual figure was $184.7 million, up 18.64% from the prior year.
• EBITDA came in at $60.4 million for Q2 2026 at Merit Medical Systems, up from $44.2 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $60.4 million in Q2 2026 to a low of $15.2 million in Q1 2022.
• Average EBITDA over 5 years is $36.5 million, with a median of $36.2 million recorded in 2024.
• Year-over-year, EBITDA surged 161.45% in 2022 and climbed 2.03% in 2025.
• Over 5 years, EBITDA stood at $30.4 million in 2022, then climbed by 10.5% to $33.6 million in 2023, then climbed by 8.78% to $36.6 million in 2024, then soared by 48.22% to $54.2 million in 2025, then increased by 11.45% to $60.4 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were $60.4 million in Q2 2026, $44.2 million in Q1 2026, and $54.2 million in Q4 2025.